PDL BioPharma Inc (PDLI)
Delisted
6 Jan 2021
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 47
0
0%
$
282.14M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 2.47
Previous Close Investors:
Day Range
2.47 2.47
Year Range
2.09 3.86
Want to track PDLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PDL BioPharma Inc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AH Andrew Heistad Mason Street Advisors LLC | 30,100 | $516,000 | $516,000 | - | - |
